Beta Bionics revenue was $110.24M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $27.6M, down 14% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BBNX annual revenue was $100.3M, with 53.9% growth year-over-year.
BBNX past revenue growth
How has BBNX's revenue growth performed historically?
On Invalid Date, Beta Bionics (NASDAQ: BBNX) reported Q1 2026 revenue of $27.63 million up 56.62% year over year. In the same quarter last year, Beta Bionics's revenue was $17.64 million.
What was Beta Bionics's revenue in 2025?
Beta Bionics's annual revenue for the twelve months ending Dec 31, 2025 was $100.25 million, a 53.94% increase year over year.
How much does Beta Bionics make in a day?
Based on Beta Bionics annual revenue for the past three years, BBNX makes an average of $161,981.74 per day.
What was Beta Bionics's annual revenue growth in the past year?
As of Q2 2026, Beta Bionics's revenue has grown 57.87% year over year. This is 46.75 percentage points higher than the US Medical Devices industry revenue growth rate of 11.12%. Beta Bionics's revenue in the past year totaled $110.24 million.
How much does Beta Bionics make in a year?
Beta Bionics's revenue by year for the past three years is:
Beta Bionics's revenue for the twelve months ending Dec 31, 2025 was $100.25 million, a 53.94% increase year over year.
Beta Bionics's annual revenue for Dec 31, 2024 was $65.12 million, a 442.93% increase from 2023.
Beta Bionics's annual revenue for 2023 was $12.00 million, a 6,601.12% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.